Study provides evidence on genetic link between new osteoporosis drug and heart attack risk Dr. Kamal Kant Kohli10 May 2023 9:30 AM ISTUK: A new study published in Arthritis & Rheumatology has shed light on the potential safety concerns related to the intake of romosozumab, a new...
Romosozumab use before antiresorptive agents tied to greater BMD responder rate in osteoporosis Dr Supreeth D R6 July 2022 8:00 PM ISTRomosozumab is a bone-forming agent with the dual effect of increasing bone formation and decreasing bone resorption.Felicia Cosman et al found in the...
Successful treatment of humeral shaft nonunion with romosozumab: A case report Dr Supreeth D R18 April 2022 9:00 AM ISTJapan: Romosozumab is a humanized monoclonal anti-sclerostin antibody (Scl-Ab) that binds and inhibits sclerostin, thereby increasing bone formation...
Romosozumab Effective in RA and Primary Osteoporosis: Study Dr. Shravani Dali26 Oct 2021 9:00 AM ISTRomosozumab increased bone mineral density (BMD) and decreased bone turnover in patients with co-occurring rheumatoid arthritis and osteoporosis...
Romosozumab substantially builds bone mineral density in hip and spine Hina Zahid13 Jan 2021 5:30 PM ISTATLANTA - New research presented at ACR Convergence, the American College Rheumatology's annual meeting, reveals that romosozumab, an osteoporosis...
Using Romosozumab prior to Antiresorptive Medication tied to better BMD gains: Study Dr. Nandita Mohan29 Dec 2020 7:55 AM ISTAccording to recent research, investigators have found that treatment with Romosozumab first produces substantial BMD gains at the total hip and...
Romosozumab offers significant benefit in osteoporosis in post menopausal women Hina Zahid16 Jun 2020 5:25 PM ISTRomosozumab offers significant benefit leading to fewer vertebral fractures and fewer other typical fractures in high risk postmenopausal women with...
Pharmacological Management of Osteoporosis in Postmenopausal Women: Endocrine Society Guideline Dr. Kamal Kant Kohli23 Feb 2020 6:00 PM ISTThe Endocrine Society today announced an update to its osteoporosis Clinical Practice Guideline to include recommendations for romosozumab, a new...
